Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ferran Abancó
Institutions:
Universitat de Vic - Universitat Central de Catalunya,
IrsiCaixa
Observed institutions:
Universitat de Vic - Universitat Central de Catalunya,
Universitat Autònoma de Barcelona,
IrsiCaixa
ORCID:
0000-0002-7297-7246
Observed ORCID:
0000-0002-7297-7246
OpenAlex ID:
A5092597517
A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity
2024
·
Leire de Campos-Mata
, Benjamin Trinité
, et al.
·
Nature Communications
·
25
PDF
Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters
2025
·
Edwards Pradenas
, Victor Urrea
, et al.
·
Journal of Translational Medicine
·
12
PDF
Analysis of tumor infiltrating CD4+ and CD8+ CDR3 sequences reveals shared features putatively associated to the anti-tumor immune response
2023
·
Andrea Aran
, Gonzalo Lázaro
, et al.
·
Frontiers in Immunology
·
10
Optimized ACE2 ‐Fc fusion proteins with picomolar neutralization activity against highly evolved SARS ‐ CoV ‐2 variants
2026
·
Ferran Abancó
, Ferran Tarrés‐Freixas
, et al.
·
Protein Science
Show more works
View as search
Works count:
4
Citation count:
47
H-index:
3
I10-index:
3
Year
Topic
Type